Abstract
Benzodiazepines produce most, if not all, of their numerous effects on the central nervous system (CNS) primarily by increasing the function of those chemical synapses that use γ-amino butyric acid (GABA) as transmitter1,2. This specific enhancing effect on GABAergic synaptic inhibition is initiated by the interaction of benzodiazepines with membrane proteins of certain central neurones, to which drugs of this chemical class bind with high affinity and specificity3,4. The molecular processes triggered by the interaction of these drugs with central benzodiazepine receptors, and which result in facilitation of GABAergic transmission, are still incompletely understood. Theoretically, benzodiazepines could mimic the effect of hypothetical endogenous ligands for the benzodiazepine receptors, although there is no convincing evidence for their existence5; in vitro studies indicate that benzodiazepines might compete with a modulatory peptide which is present in the supramolecular assembly formed by GABA receptor, chloride ionophore and benzodiazepine receptor and which reduces the affinity of the GABA receptor for its physiological ligand6. The mechanisms of action of benzodiazepines at the molecular level are likely to be better understood following our recent discovery of benzodiazepine derivatives, whose unique pharmacological activity is to prevent or abolish in a highly selective manner at the receptor level all the characteristic centrally mediated effects of active benzodiazepines. Here, we describe the main properties of a representative of this novel class of specific benzodiazepine antagonists.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Haefely, W. et al. in Mechanism of Action of Benzodiazepines (eds Costa, E. & Greengard, P.) 131–151 (Raven, New York, 1975).
Costa, E., Guidotti, A., Mao, C. C. & Suria, A. Life Sci. 17, 167–186 (1975).
Braestrup, C. & Squires, R. F. Proc. natn. Acad. Sci. U.S.A. 74, 3805–3809 (1977).
Möhler, H. & Okada, T. Science 198, 849–851 (1977).
Möhler, H. Trends Pharmac. (in the press).
Guidotti, A., Toffano, G. & Costa, E. Nature. 275, 553–555 (1978).
Pieri, L. et al. Drug Res. (in the press).
Boissier, J.-R. & Simon, P. Thérapie. 15, 1170–1174 (1960).
Blanchard, J. C., Boireau, A., Garret, C. & Julou, L. Life Sci. 24, 2417–2420 (1979).
Pole, P., Möhler, H. & Haefely, W. Naunyn-Schmiedebergs Archs Pharmak. 284, 319–337 (1974).
Keller, H. H., Schaffner, R. & Haefely, W. Naunyn-Schmiedebergs Archs Pharmak. 294, 1–7 (1976).
Burkard, W. P., Pieri, L. & Haefely, W. Adv. biochem. Psychopharmac. 15, 315–324 (1976).
Biggio, G., Costa, E. & Guidotti, A. Adv. biochem. Psychopharmac. 15, 325–335 (1976).
Stohler, H. R. in Current Chemotherapy. (eds Siegenthaler, W. & Lüthy, R.) 147–148 (American Society for Microbiology, Washington DC, 1978).
Pax, R., Bennett, J. L. & Fetterer, R. Naunyn-Schmiedebergs Archs Pharmak. 304, 309–315 (1978).
Bennett, J. L. J. Parasit. (in the press).
Di Liberti, J. & O'Brien, M. L. J. Pediat. 86, 106–107 (1975).
Rupreht, J. Anesthesiology 53, 180–181 (1980).
Bell, E. F. J. Pediat. 87, 803–804 (1975).
Christensen, K. N. & Hüttel, M. Anesthesiology 51, 187 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunkeler, W., Möhler, H., Pieri, L. et al. Selective antagonists of benzodiazepines. Nature 290, 514–516 (1981). https://doi.org/10.1038/290514a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/290514a0
This article is cited by
-
Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice
Psychopharmacology (2018)
-
Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies
Metabolic Brain Disease (2018)
-
γ-Aminobutyric acid (GABA) signalling in plants
Cellular and Molecular Life Sciences (2017)
-
GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC
Neuropsychopharmacology (2015)
-
Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine
Neuropsychopharmacology (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.